ACHC:NSD-Acadia Healthcare Company, Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 18.35

Change

-0.09 (-0.49)%

Market Cap

USD 1.64B

Volume

1.65M

Average Target Price

USD 35.50 (+93.46%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides mental health rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. As of December 31, 2018, the company operated a network of 583 behavioral healthcare facilities with 18,084 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.

Company Website : http://www.acadiahealthcare.com

Address : 6100 Tower Circle, Suite 1000 37067,Franklin,USA

Employees : 28,400

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.70

52 Week High : 35.30

Short Ratio : 12.40

52 Week Low : 11.09

Shorted Shares : 11,735,915

200 Day Moving Average : 30.36

Shorted Shares Previous Month : 11,628,240

50 Day Moving Average : 25.83

Shares Held By Insiders : 2%

Short Percentage : 13.00%

Shares Held by Institutions : 119%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-03-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys, Inc

+3.59 (+2.00%)

 USD5.23B 42.11 31.01
LHCG LHC Group, Inc

+6.34 (+4.74%)

 USD3.92B 40.52 25.53
ENSG The Ensign Group, Inc

-0.76 (-1.98%)

 USD1.82B 17.16 17.32
HCSG Healthcare Services Group, Inc

+0.93 (+4.05%)

 USD1.69B 26.14 17.39
ADUS Addus HomeCare Corporation

-1.41 (-2.04%)

 USD1.07B 47.17 20.62
PRSC The Providence Service Corpora..

-0.11 (-0.20%)

 USD0.77B 32.90 17.53
AMEH Apollo Medical Holdings, Inc

-0.82 (-5.97%)

 USD0.49B 35.23 12.70
PNTG The Pennant Group, Inc

-1.35 (-8.70%)

 USD0.43B N/A 32.51
SGRY Surgery Partners, Inc

-0.28 (-4.11%)

 USD0.35B 63.00 13.55
TVTY Tivity Health, Inc

-0.14 (-2.18%)

 USD0.34B 8.78 6.68

ETFs Containing ACHC

Symbol Name Weight Mer Price(Change) Market Cap

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -44.76% 22% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.76% 22% F 20% F
Trailing 12 Months  
Capital Gain -38.13% 50% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.13% 50% F 34% F
Trailing 5 Years  
Capital Gain -73.86% 33% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -73.86% 33% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -16.50% 19% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.50% 19% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 16.29% 100% A+ 78% C+
Risk Adjusted Return -101.28% 13% F 3% F
Market Capitalization 1.64B 78% C+ 81% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 14.87 92% A- 52% F
Price/Book Ratio 0.65 93% A 79% C+
Price / Cash Flow Ratio 4.92 61% D- 42% F
EV/EBITDA 9.21 76% C 33% F
Management Effectiveness  
Return on Equity 4.49% 47% F 55% F
Return on Invested Capital 6.77% 33% F 62% D-
Return on Assets 3.87% 53% F 77% C+
Debt to Equity Ratio 123.95% 19% F 17% F
Technical Ratios  
Short Ratio 12.40 22% F 6% F
Short Percent N/A N/A N/A N/A N/A
Beta 0.70 63% D 67% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.